Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes

NCT03887416 is registered in ClinicalTrials.gov with LM Diagnósticos S.L. as lead sponsor.

NCT NCT03887416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03887416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
Lead sponsor
LM Diagnósticos S.L.
Phase
Phase 4
Overall status
Unknown status
Start date
April 12, 2019
Completion date
February 29, 2020
Enrollment
225 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes